Glebov et al., Antidepressant drug prescription and incidence of COVID-19: a retrospective cohort study, medRxiv, doi:10.1101/2022.12.15.22283507 (Preprint)
Retrospective 5,664 mental health patients in the UK, showing lower risk of COVID-19 cases with recent antidepressant prescriptions overall, and for the subset of patients receiving SSRIs.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2022.12.15.22283507; this version posted December 20, 2022. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
Antidepressant drug prescription and incidence of
COVID-19: a retrospective cohort study
Oleg O. Glebov1,2* Ph.D., Christoph Mueller2,3 M.D., Robert Stewart2,3 M.D., Dag Aarsland2,4
M.D., Gayan Perera2 Ph.D.
1
Institute of Neuroregeneration and Neurorehabilitation, Department
Pathophysiology, School of Basic Medicine, Qingdao University, Shandong, China.
of
2
Institute of Psychiatry, Psychology and Neuroscience, King’s College London,
London, UK.
3
South London and Maudsley NHS Foundation Trust, London, UK.
4
Centre for Age-related research, Stavanger University Hospital, Stavanger, Norway.
* contact e-mail: oleg.glebov@kcl.ac.uk
Word count: 1292 (Main Text)
Key points
Question
Is there an association between prescription of antidepressants and incidence of COVID-19
in the general population?
Findings
In this retrospective cohort study of mental health outpatients with a recent (1-3 months)
antidepressant prescription, there was a statistically significant 40% decrease in positive
COVID-19 tests. This association was specifically observed for the most commonly
prescribed antidepressant class, Selective Serotonin Reuptake Inhibitors, and remained
when adjusted for socioeconomic parameters and physical health.
Meaning
Antidepressant prescription was associated with lower incidence of COVID-19 in the
community, warranting further investigation as prophylactics in prospective clinical studies.
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
medRxiv preprint doi: https://doi.org/10.1101/2022.12.15.22283507; this version posted December 20, 2022. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .
Abstract
While antidepressant drugs (ADs) have shown some efficacy in treatment of COVID-19, their
preventative potential remains unexplored. To investigate association between AD and
COVID-19 incidence in the community, we analysed data from community-living, nonhospitalized adults admitted to inpatient care of the South London&Maudsley (SLaM) NHS
Foundation Trust during the 1st wave of COVID-19 pandemic in the UK. Prescription of ADs
within the period of 1 to 3 months before admission was associated with an approximately
40% decrease in positive COVID-19 test results when adjusted for socioeconomic
parameters and physical health. This association was specifically observed for ADs of the
Selective Serotonin Reuptake Inhibitor (SSRI) class. These results suggest that ADs,
specifically SSRIs, may help prevent COVID-19 infection in the community. Definitive
determination of AD preventative potential warrants prospective studies in the wider general
population.
Main text
More than 2.5 years since the declaration of the global COVID-19 pandemic, it remains a
major public health burden across the world, with further waves of infection more likely than
not. To this day, the only available method for prevention of..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.